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intraoperative time to reliably create. The size of the valve is
crafted to match the RV outlet regardless of the augmentation
size.
References
1. Turrentine MW, McCarthy RP, Vijay P, McConnell KW, Brown JW.
PTFE monocusp valve reconstruction of the right ventricular outflow
tract. Ann Thorac Surg. 2002;73:871-80.
2. Gundry SR, Razzouk AJ, Boskind JF, Bansal R, Bailey LL. Fate of the
pericardial monocusp pulmonary valve for right ventricular outflow tract
reconstruction. Early function, late failure without obstruction. J Thorac
Cardiovasc Surg. 1994;107:908-12.
3. Roughneen PT, DeLeon SY, Parvathaneni S, Cett F, Eidem B,
Vitullo DA. The pericardial membrane pulmonary monocusp: surgical
technique and early results. J Card Surg. 1999;14:370-4.
4. Morita K, Kurosawa H, Nomura K, Naganuma H, Matsumura H,
Kawada N, et al. Right ventricular outflow tract reconstruction with
PTFE mono-cusped trans annular patch for tetralogy of Fallot. Kyobu
Geka. 2001;(8 Suppl):631-6.
5. Yamagishi M, Kurosawa H. Outflow reconstruction of tetralogy of Fal-
lot using a Gore-Tex valve. J Thorac Cardiovasc Surg. 1996;112:33-7.
6. Iemura J, Oku H, Otaki M, Kitayama H. Expanded polytetrafluoroethy-
lene monocuspid valve for right ventricular outflow tract reconstruction.
J Thorac Cardiovasc Surg. 2007;133:640-7.
7. Bigras JL, Boutin C, McCrindle BW, Rebevka IM. Short term effect of
monocuspid valves on pulmonary insufficiency and clinical outcome af-
ter surgical repair of tetralogy of Fallot. J Cardiovasc Surg(Torino).
2001;42:17-21.
8. Bechtel JF, Lange PE, Sievers HH. Optimal size of a monocusp patch for
reconstruction of a hypoplastic pulmonary root: an experimental study in
pigs. Eur J Cardiothorac Surg. 2005;27:807-14.
9. Koh M, Yagihara T, Uemura H, Kagisaki K, Hagino I, Ishizaka T, et al.
Long termoutcome of right ventricular outflow tract reconstruction using
a hand made tri leaflet conduit. Eur J Cardiothorac Surg. 2005;807-14.
10. Quintessenza JA, Jacobs JP, Morell VO, Giroud JM, Boucek RJ. Initial
experience with a bicuspid polytetrafluoroethylene pulmonary valve in
41 children and adults: a new option for right ventricular outflow tract
reconstruction. Ann Thorac Surg. 2005;79:924-31.
TABLE 4. Comparison of echocardiographic and MRI assessment of RV outlet valve
Patient operation date Years of follow-up Echocardiography reports: RV outlet valve
MRI regurgitant fraction:
RV outlet valve
September 2, 2004 2.7 Mild pulmonary incompetence 12.0%
September 8, 2004 2.6 Minimal pulmonary incompetence 16.0%
September 30, 2004 2.6 Mild pulmonary incompetence 23.0%
February 1, 2005 2.2 Mild pulmonary incompetence 11.5%
February 17, 2005 2.2 Mild plus pulmonary incompetence 18.0%
May 17, 2005 1.9 Mild pulmonary incompetence 18.0%
May 24, 2005 1.9 Moderate pulmonary incompetence 4.0%
October 15, 2005 1.5 Mild pulmonary incompetence 6.0%
October 20, 2005 1.5 Mild pulmonary incompetence 26.5%
December 1, 2005 1.4 No reports 10.0%
February 8, 2006 1.2 Minimal pulmonary incompetence 10.0%
February 15, 2006 1.2 Mild pulmonary incompetence 29.0%
August 23, 2006 0.7 Mild pulmonary incompetence 9.0%
RV, Right ventricular; MRI, magnetic resonance imaging.
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Dr J. Brown (Indianapolis, Ind). Dr Nunn and colleagues are to
be commended on their development of another relatively simple296 The Journal of Thoracic and Cardiovascular Surgery c Autechnique to reconstruct the pulmonary valve with 0.1-mm PTFE
membrane in patients who require a transannular patch. I have to
admit that studying their illustrations and seeing the video clarified
this technique immensely for me. Reading the abstract, I was a little
confused. But you did a wonderful job in explaining how this valve
works and how it’s oriented in the RV outflow tract.
This technique lengthens the leading edge, or free edge, of the
reconstructed pulmonary valve and has the potential advantage of
enlarging the pulmonary valve to a greater diameter than can be
accomplished with a monocusp valve and may shorten the leaflet
closing time. The technique also orients the commissures of the
new valve in a vertical manner as opposed to the monocusps, where
the closure is in the horizontal manner.
The monocusp technique, using this material that my colleagues
and I have used successfully at Indiana for more than 13 years and
more than 200 patients, allows us to double the circumference of the
native RV outflow tract, but it seems that this technique might allow
you to enlarge it even further. I have several questions. Do you use
aspirin postoperatively in your patients?
Dr Nunn. I haven’t.
Dr Brown. Can you make this outflow tract reconstruction too
large so that when you close the sternum it’s compressed and this
would deform this valve?
Dr Nunn. It’s possible. But I think that the bileaflets, because
they’re held apart by that pledgeted suture, would still function to
a degree with redundancy in their free edge, which is implied in
your question, so I think it would still work, but I haven’t had that
experience yet.
Dr Brown. There obviously is some artwork involved with this
technique to know how large to make the outflow tract patch itself.
Do you have a rule of thumb that you use for how big youmake it, or
how big of an orifice through this outflow tract you want to have at
the end of your repair?
Dr Nunn. I don’t have a rule of thumb. For the tetralogies re-
paired primarily that needed this, I’ve used a 25-mm wide PTFE
strip as the augmenting patch, but it can be larger.
Dr Brown. In at least 1 of your patients you had a 30% regurgi-
tant fraction in this bileaflet or bicuspid valve. What was the nature,gust 2008
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Dwhy did that valve leak, and why is there at least a small amount of
leakage in all of these valves? Where does the leakage occur?
Dr Nunn. With the technique of MRI used here in a number of
these patients, the normal mitral and aortic valves were assessed for
their competence, and they regularly returned a 5% regurgitant frac-
tion by this technique. So that a median regurgitant fraction of 11%
isn’t as bad as it may appear at first glance. That’s the first thing.
I think the other is that I don’t think I’ve made them all perfect,
and I’m sure there is a learning curve in that. I’m convinced that I’m
still learning. So whether the 30% valve was just a bad day, I don’t
know. When I started this, I thought that if they were going to fail
they were going to fail as a monocusp does, and I’d left the patient
with a reasonable chance of progressing to later growth and the need
for another type of valve, as most repaired tetralogies with outflow
tract patches have. So I felt comfortable that I could use this tech-
nique. I would have been happy at that point to accept a 30% regur-
gitant fraction. So to see them functioning sometimes at near-normal
valve competence, as assessed by this technique of MRI, I was very
happy with that.
Dr Brown. Our experience with a monocusp has been a little
better in that at approximately 12 years postoperatively there is
only moderate or greater regurgitation in approximately 50% at
12 years. It’s promising that at least this technique may reduce
that substantially, and for that I congratulate you for this new tech-
nique to further reduce the late development of pulmonary insuffi-
ciency in this important group of patients.
Dr G.-W. He (Hong Kong, China). Congratulations for an ele-
gant technique. My question is regarding the use of the monocusp
valve. It was used in the early 1970s and 1980s. The reason that
the monocusp was abandoned in the 1980s in most centers was
because it was not functioning after 6 months for 2 reasons: First,
some of the monocusps were absorbed, so it was not functioning.
Second, some of the monocusps were calcified, so was not function-
ing because it was attached to the wall.
This is why I developed a new technique to create a monocusp-
bearing pericardium patch. I reported this technique 2 days ago at
the World Society for Congenital Heart Surgery meeting. I do be-
lieve that the use of a monocusp-bearing patch cannot be abandoned
because in many of the patients who need RV outflow tract recon-
struction, there are some remnants of the native valves. In my prac-
tice, in the last few years, I did 74 tetralogy repairs. Two thirds of
them have at least 1 or 2 valves left. In such cases I do not think
we really need to go too far to use your bicuspid pericardial patch,The Journal of Thorwhich has a lot of foreign body tissue in the low pressure pulmonary
system that may need coagulation therapy. Do you really think your
technique can be used for all patients with tetralogy or do we still
need to use the monocusp?
Dr Nunn. Like you, I leave any useful valve remnants in the RV
outflow tract and that’s often 2 leaflets. So I share your desire to pre-
serve pulmonary valve tissue.
I haven’t seen any evidence of pulmonary emboli or thrombosis
in the RV outlet or pulmonary arteries in these patients in follow-up.
It may happen, but it hasn’t yet.
I agree with you that pericardial monocusps do deteriorate. In
this series, of the 22 pericardial monocusps, 5 were replaced, 1
with a bileaflet PTFE valve and 1 with homografts or freestyle por-
cine valves. My findings were that the monocusps were stuck to the
free wall.
Dr He. I used the monocusp valve formed from the pericardium
itself, fold up and sewn on the 2 sides. I think the results would
be better than the traditional method that uses 1 patch sewn to an-
other, because the calcification and the absorbable problem would
be less.
Dr J. Jacobs (St Petersburg, Fa). In 2005, JimQuintessenza and
I published our initial experience with 41 patients with PTFE bicus-
pid valves in older, larger patients. Our series is now up to 90 pa-
tients with a median age of 14.6 years, and our follow-up is about
up to 6.4 years; 88 of these 90 valves are still functional and 2 of
them had to be replaced. We initially used 0.6-mm PTFE, and
now we’ve switched to 0.1-mm PTFE.
Would you use the valve that you’ve described in an older pa-
tient, a teenager, with late pulmonary insufficiency? If so, would
you use 0.6-mm or 0.1-mm PTFE?
Dr Nunn.A number of these patients are in that age range. I still
use the 0.1-mm PTFE. The 0.6-mm PTFE just adds momentum to
the leaflets and stiffens the valve enough that it probably doesn’t
finish its opening or closing when the next cardiac cycle arrives.
So that’s one of the reasons I stayed with the 0.1. But having
done that, it’s a fragile membrane to work with, and so using a larger
leaflet extending well into the pulmonary artery spreads the wall
stress of the PTFE and allows tension to be taken off that posterior
fixing suture.
Dr Jacobs.Wewere initially using the 0.6. After discussion with
John Brown and having 1 failure when it got a little calcified, we
switched to the 0.1, and we’ve been pretty happy with that by mak-
ing a long leaflet just like you described.acic and Cardiovascular Surgery c Volume 136, Number 2 297
